13 October 2020

Club Drug Founder Dr Owen Bowden-Jones and CNWL Researcher Dr Dima Abdulrahim have held the first of a series of five training sessions on the treatment of the harms produced by novel psychoactive substances.

These are being delivered online to specialists from Belarus, Moldova, Georgia, Ukraine and Pakistan and is based around their 'Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances'. 

This is being delivered by EU-ACT Project, in conjunction with the EU4MD, European Union 4 Monitoring Drugs, a Project of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); and the Novel Psychoactive Treatment United Kingdom Network (NEPTUNE).

The sessions aim at increasing awareness of the latest trends in treating the effects on the persons of the new psychoactive substances, and club drugs such as ecstasy and ketamine.

Dr Bowden-Jones and Dr Abdulrahim recently jointly published a new clinicians’ handbook on club drugs and novel psychiatric substances.

The book is on this link: https://www.cambridge.org/core/books/club-drugs-and-novel-psychoactive-substances/00E1CB02C03A1E18980F8F3E2209F402